PLA2R1 and nephrotic syndrome: Considering the high specificity of serum PLA2R antibodies in patients with PMN, it is recommended that PLA2R antibody‐positive patients with nephrotic syndrome undergo dynamic testing first instead of immediate renal biopsy.141, 142